Axa SA (CS) Given a €25.00 Price Target at Kepler Capital Markets
Axa SA (EPA:CS) has been given a €25.00 ($26.32) price objective by investment analysts at Kepler Capital Markets in a report issued on Tuesday. The brokerage presently has a “buy” rating on the stock.
A number of other research analysts also recently issued reports on the stock. Societe Generale set a €29.00 ($30.53) price target on shares of Axa SA and gave the stock a “buy” rating in a research report on Tuesday, September 6th. Macquarie set a €15.30 ($16.11) price objective on shares of Axa SA and gave the stock a “sell” rating in a report on Tuesday, August 2nd. JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Axa SA in a report on Wednesday, November 2nd. Morgan Stanley set a €24.30 ($25.58) price objective on shares of Axa SA and gave the stock a “buy” rating in a report on Tuesday, August 9th. Finally, Deutsche Bank AG reaffirmed a “buy” rating on shares of Axa SA in a report on Wednesday, October 26th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and fifteen have given a buy rating to the company’s stock. Axa SA currently has a consensus rating of “Buy” and an average target price of €23.68 ($24.93).
Shares of Axa SA (EPA:CS) opened at 21.81 on Tuesday. The stock’s 50 day moving average is €21.09 and its 200-day moving average is €19.62. Axa SA has a one year low of €16.11 and a one year high of €26.02. The firm has a market cap of €52.70 billion and a P/E ratio of 9.66.
Axa SA Company Profile
AXA SA (AXA) is a holding company engaged in the business of financial protection. The Company operates in five segments: Life & Savings, Property & Casualty, International Insurance, Asset Management and Banking. The Company offers a range of life and savings products, including individual and group savings retirement products, life and health products.
Receive News & Stock Ratings for Axa SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axa SA and related stocks with our FREE daily email newsletter.